New Non-Hodgkins Lymphoma Treatment Ready for Human Clinical Trials

Submitted by Vic Wed 01/14/2009

Share on Tumblr

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

InNexus Biotechnology Inc., located in Toronto Canada, said they are ready to move their treatment aimed at Non-Hodgkin's Lymphoma into human clinical trials. The company showed that their treatment eliminated all lymphocytes with a CD20 marker safely in primates. Why is CD20 important? CD20 is also the target of FDA approved drugs, Rituxan and Zevalin. InNexus are currently working with the FDA to outline the design of their clinical study on humans.

Call (877) 399-6937 or click here to learn more about Cancer Treatment options.

Support Groups

SupportGroups.com

For individuals, friends and families who are looking to connect during life's challenging times. Share personal experiences, evaluate information and get support during times of need, illness, treatment or recovery.

Cancer Support Groups

Find a Treatment Facility Near You

Click on a state below to find Lymphoma treatment options that could be right for you.

Select a State Below

The information provided on the Lymphoma Information Network is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her health professional. This information is solely for informational and educational purposes. The publication of this information does not constitute the practice of medicine, and this information does not replace the advice of your physician or other health care provider. Neither the owners or employees of LymphomaInfo.net nor the author(s) of site content take responsibility for any possible consequences from any treatment, procedure, exercise, dietary modification, action or application of medication which results from reading this site. Always speak with your primary health care provider before engaging in any form of self treatment. Please see our Legal Statement for further information.